Climb International Options (CLMB) Q2 2023 Earnings Name Transcript

Climb International Options (NASDAQ:CLMB) Q2 2023 Earnings Convention Name August 3, 2023 8:30 AM ET

Firm Members

Sean Mansouri – IR Advisor, Elevate IR

Dale Foster – CEO

Andrew Clark – CFO

Convention Name Members

Vincent Colicchio – Barrington Analysis


Good morning, everybody, and thanks for collaborating in in the present day’s convention name to debate Climb International Options’ monetary outcomes for the Second Quarter Ended June 30, 2023.

Becoming a member of us in the present day are Climb’s CEO, Mr. Dale Foster; the corporate’s CFO, Mr. Drew Clark; and the corporate’s Investor Relations adviser, Mr. Sean Mansouri with Elevate IR.

By now, everybody ought to have entry to the second quarter 2023 earnings press launch, which was issued yesterday afternoon at roughly 4:05 p.m. Japanese Time. The discharge is on the market within the Investor Relations part of Climb International Options web site at This name can even be obtainable for webcast replay on the corporate’s web site. Following administration’s remarks, we’ll open the decision on your questions.

I might now like to show the decision over to Mr. Mansouri for introductory feedback.

Sean Mansouri

Thanks, Carmen.

Earlier than I introduce Dale, I might prefer to remind listeners that sure feedback made on this convention name and webcast are thought-about forward-looking statements below the Non-public Securities Litigation Reform Act of 1995. These forward-looking statements are topic to sure identified and unknown dangers and uncertainties in addition to assumptions that might trigger precise outcomes to vary materially from these mirrored in these forward-looking statements. These forward-looking statements are additionally topic to different dangers and uncertainties which might be described now and again within the firm’s filings with the SEC. Don’t place undue reliance on any forward-looking statements, that are being made solely as of the date of this name. Besides as required by legislation, the corporate undertakes no obligation to revise or publicly launch the outcomes of